XBI icon

SPDR S&P Biotech ETF

201 hedge funds and large institutions have $2.32B invested in SPDR S&P Biotech ETF in 2016 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 64 increasing their positions, 56 reducing their positions, and 34 closing their positions.

Holders
201
Holders Change
+6
Holders Change %
+3.08%
% of All Funds
5.37%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.05%
New
43
Increased
64
Reduced
56
Closed
34
Calls
$539M
Puts
$880M
Net Calls
-$341M
Net Calls Change
-$69.5M
Name Market Value Shares Shares
Change
Shares
Change %
MMA
226
Miracle Mile Advisors
California
-5,895 Closed
AGM
227
Alpine Global Management
New York
-5,801 Closed
JT
228
Jump Trading
Illinois
-5,666 Closed
BUB
229
BBVA USA Bancshares
Texas
-4,600 Closed
GT
230
Glenmede Trust
Pennsylvania
-850 Closed
AF
231
Allworth Financial
California
-702 Closed
IPC
232
Independent Portfolio Consultants
Florida
-495 Closed
TFA
233
Transamerica Financial Advisors
Florida
-244 Closed
CAPTRUST Financial Advisors
234
CAPTRUST Financial Advisors
North Carolina
-240 Closed
NC
235
NewSquare Capital
Pennsylvania
-226 Closed
WIC
236
Woodmont Investment Counsel
Tennessee
-150 Closed
MC
237
Maplelane Capital
New York
-1 Closed
UOC
238
UBS O'Connor
Illinois
Capital Fund Management (CFM)
239
Capital Fund Management (CFM)
France
Jennison Associates
240
Jennison Associates
New York
KCM
241
Kingdon Capital Management
New York
EAM
242
EverPoint Asset Management
Connecticut
PIM
243
Partner Investment Management
California
Parallax Volatility Advisers
244
Parallax Volatility Advisers
California
$0 3
JFGIW
245
Johnson Financial Group Inc (Wisconsin)
Wisconsin
CI
246
Cowen Inc
New York
PHS
247
PFM Health Sciences
California
TI
248
Telemetry Investments
New York
PA
249
Perceptive Advisors
New York
GTC
250
Ghost Tree Capital
New York